Product Details:
Minimum Order Quantity | 1 Vial |
Brand | abbive |
Dose | 50 |
Packaging Size | 0.5 |
Brand Name | abbive |
Manufacturer | abbive |
Usage/Application | personal |
Packaging Type | 1*1 |
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Strength | 400 mg+ 100 mg |
Packaging Size | 28 tablets |
Composition | sofosbuvir + velpatasvir |
Treatment | his prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. |
Prescription/Non prescription | Non prescription |
Form | Tablet |
Brand | Velakast |
Manufacturer | aprazer |
Shelf life | 36 month |
Also gives | commercial |
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Strength | 500 mg |
Packaging Size | 28 tablets |
Packaging Type | Bottle |
Composition | sofosbuvir 400 mg & velpatasvir 100 mg |
Treatment | To treat chronic hepatitis C (HCV) infection. |
Manufactured By | hatero healthcare |
Brand | Velasof |
Prescription/Non prescription | Prescription |
Form | Tablet |
Also gives | Third Party Manufacturing |
Velasof tablet contains the active components Sofosbuvir and Velpatasvir. It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velasof tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.
If you have a known allergy or hypersensitivity to Velasof tablet or any of the components of the medication, you should not take it. The safety and efficacy of sofosbuvir and velpatasvir combination therapy have not been established in children under 18. Its use in the pediatric population is currently limited. It is recommended to use alternative treatment options or adjust the dosage in these cases.Additional Information:
Product Details:
Minimum Order Quantity | 1 Piece |
Strength | 10 g |
Prescription/Non prescription | Prescription |
Packaging Size | 10ML |
Shelf life | (2 - 8 DegreeC). Do not freeze. |
Country of Origin | Made in India |
Immunorel 10gm Injection 100ml is an immunostimulant drug containing the active ingredient Human normal immunoglobulin that belongs to the class of immunoglobulin derivatives. It is used as a replacement therapy for individuals with primary immunodeficiency disorders (PIDs), where the body's immune system cannot produce sufficient antibodies to fight off infections. The medication is also used to modulate or regulate the immune system in certain autoimmune and inflammatory conditions. It can help reduce excessive inflammation and suppress abnormal immune responses.
This drug is contraindicated in individuals with known hypersensitivity or allergy to human immunoglobulin or its components.There is a chance of developing blood clots during the treatment with Immunorel 10gm Injection 100ml treatment hence it is recommended to monitor the blood viscosity and ensure adequate hydration. If you have a selective IgA deficiency, there is a risk of developing antibodies against IgA. In such cases, normal human immunoglobulin should be used cautiously or avoided altogether. Inform your physician if you have a history of IgA deficiency. After receiving Immunorel 10gm Injection 100ml, it is possible to experience a temporary decrease in the concentration of white blood cells, a condition named as neutropenia (low neutrophil count) which resolves spontaneously within a week. It is not recommended for children younger than 12 years since the effects of human immunoglobulin in this population is unknown.
Additional Information:
Product Details:
Packaging Size | 1 x 34 Tablets |
Strength | 200 mg |
Composition | Favipiravir |
Treatment | covid-19 mild |
Prescription/Non prescription | Prescription |
Form | Tablet |
Brand | FabiFlu |
Manufacturer | Glenmark Pharmaceuticals |
Packaging Type | Box |
Favipiravir induces a rapid mutation rate of the virus RNA polymerase complex, which results in a large proportion of nonviable viruses within the total virus population.Favipiravir is an antiviral medicine used for the treatment of severe and life-threatening illness with confirmed or suspected infection caused by SARS-CoV.